CS MEDICA will publish its interim report for the fourth quarter 2021/2022 on Friday, the 11th of November at 08:00 CEST. The highlights of the report will be presented in a webinar at 11:00 CET on the same day.

Lone Henriksen, CEO and Founder of CS MEDICA, and Gitte Lund, CFO and Founder of CS MEDICA, will present and also be available for questions. The report and session will be in English.

The live-streamed session will be divided into a 15-minute presentation followed by QA, via the chat function at the webcast. Any pre-defined questions related to the quarterly report can be sent to glh@cs-medica.com. 

Agenda for the Event
Presentation of the Fourth Quarter Interim report

Date and time
November 18, 2022, from 11:00 – 11:30 CEST

Webcast link
Live Webcast link >>.

For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: lh@cs-medica.com
Website: https://www.cs-medica.com/

CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.

The company is listed on Spotlight Stock Market in Stockholm (symbol: "CSMED"). For more information about CS MEDICA cs-medica.com.